The IMITHEA Group and Roche Diagnostics Hellas are joining forces in a strategic partnership that is setting new standards in laboratory testing and, more broadly, in the field of diagnostics in Greece.
Through this partnership, Roche Diagnostics, a global leader in diagnostic solutions, is playing a key role in the complete modernization of the central laboratories at Henry Dunant Hospital and the General Clinic, Kyanos Stavros, and Genesis General Clinic in Thessaloniki, as well as the General Clinic of Rhodes and the General Clinic of Kozani, key pillars in the IMITHEA Group network, with cutting-edge technology and state-of-the-art reagents, upgrading the healthcare services provided to patients through the integration of advanced diagnostic solutions.
These internationally recognized systems meet the most demanding laboratory accreditation standards for all biochemical, immunological, and hematological tests.
Commenting on the partnership, the Executive Chairman of the IMITHEA Group, Mr. Themos Charamis, stated: “Quality and safety are key objectives for Henry Dunant and the IMITHEA Group and guide every step we take, continuously providing patients with the most advanced and reliable tools.
Our collaboration with Roche Diagnostics, a global leader in diagnostic technology, reaffirms our commitment to quality services, seals our shared vision, and lays the groundwork for new, innovative, and pioneering steps in the healthcare sector.”
For his part, the CEO of Roche Diagnostics Hellas, Mr. Siete Braak, emphasized: “Our collaboration with the IMITHEA Group sets new standards for the quality of healthcare in Greece. By supporting 70% of clinical decisions throughout a patient’s journey, diagnostic tests play a decisive role in prevention, early diagnosis, and disease management, as well as in the effort to create more sustainable healthcare systems.
Roche Diagnostics provides access to advanced diagnostic tools and tests, leveraging its global expertise and investing in fruitful partnerships. By joining forces with the IMITHEEA Group, we are making modern, reliable, and innovative solutions available to patients that can change not only their experience but also their lives.”
Through the strategic partnership between the HMITHEA Group and Roche Diagnostics Hellas, patients are better protected with the most reliable diagnostic solutions, while equipping healthcare professionals with medically valuable knowledge essential for making faster and more accurate decisions—reducing the burden of disease in critical areas such as Cardiometabolic Diseases, Neurology, Oncology, and Infectious Diseases. This enables both a transformation of the patient’s care journey and the delivery of improved health outcomes.